2. Academic Validation
  3. A non-viral CRISPR/Cas9 delivery system for therapeutically targeting HBV DNA and pcsk9 in vivo

A non-viral CRISPR/Cas9 delivery system for therapeutically targeting HBV DNA and pcsk9 in vivo

  • Cell Res. 2017 Mar;27(3):440-443. doi: 10.1038/cr.2017.16.
Chao Jiang 1,  Miao Mei 1,  Bin Li 2,  Xiurui Zhu 3,  Wenhong Zu 1,  Yujie Tian 1,  Qiannan Wang 1,  Yong Guo 3,  Yizhou Dong 2,  Xu Tan 1
Affiliations

Affiliations

  • 1 School of Pharmaceutical Sciences, Center for Infectious Disease Research, School of Medicine, Tsinghua University, Tsinghua-Peking Center for Life Sciences, Beijing 100084, China.
  • 2 Division of Pharmaceutics and Pharmaceutical Chemistry, College of Pharmacy, The Ohio State University, Columbus, OH 43210, USA.
  • 3 Department of Biomedical Engineering, School of Medicine, Tsinghua University, Beijing 100084, China.
PMID: 28117345 DOI: 10.1038/cr.2017.16
Figures
Products